Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BCAC

Brookline Capital Acquisition (BCAC) Stock Price, News & Analysis

About Brookline Capital Acquisition Stock (NASDAQ:BCAC)

Advanced Chart

Key Stats

Today's Range
$2.61
$3.11
50-Day Range
$0.36
$22.71
52-Week Range
$9.50
$27.74
Volume
29,998 shs
Average Volume
39,682 shs
Market Capitalization
$19.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Brookline Capital Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. It intends to acquire companies in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

Receive BCAC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brookline Capital Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCAC Stock News Headlines

The difference between pros and amateurs
The #1 Mistake Amateur Traders Make (and How Pros Beat Them) Most traders lose because they chase too many stocks at once. Pros know better: They focus on one setup at a time — and hit it hard. This "Market Wizard" built a 20-year winning streak for his clients doing just that.
Q2 2023 electroCore, Inc. Earnings Call
LFAC LF Capital Acquisition Corp. II
See More Headlines

BCAC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Brookline Capital Acquisition investors own include Advanced Micro Devices (AMD), Meta Platforms (META), Alibaba Group (BABA), Banxa (BNXAF), Crane (CR), Ford Motor (F) and GS Acquisition Holdings Corp II (GSAH).

Company Calendar

Today
5/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:BCAC
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-480,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
5,451,000
Market Cap
$19.90 million
Optionable
Not Optionable
Beta
-0.03
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:BCAC) was last updated on 5/16/2025 by MarketBeat.com Staff
From Our Partners